Faculty of Health Sciences, University of Beira Interior, Av. Infante D.Henrique, 6200-506, Covilhã, Portugal.
Int J Clin Pharm. 2013 Feb;35(1):30-6. doi: 10.1007/s11096-012-9699-y. Epub 2012 Sep 28.
Many drugs are prescribed outside the terms of the marketing authorization ("off-label"). Several studies have shown that this is a common practice in various European healthcare settings.
This study aimed to quantify and characterize off-label drug prescribing in children admitted to a Portuguese Paediatric Unit (PEU).
This study was conducted in the Paediatric Unit of the university teaching hospital of Cova da Beira Hospital Centre (CHCB), Covilhã, located in the Eastern Central Region of Portugal.
A descriptive study was conducted, including a sample of 700 children, randomly selected from those admitted between January to October 2010. Drug prescription was assessed by retrospective review of clinical files.
Off-label prescribing was defined as the utilization of a drug at an indication, age, dosage, frequency or route of administration different from those recommended in the Summary of Product Characteristics (SPC). For purposes of this study only the medicines prescribed to be used after discharge from the hospital were studied.
364 boys and 336 girls, aged from 4 days to 18 years, were included in this study. Of the 724 medicines prescribed, 32.2 % were off-label. At least one drug was used off-label in 28.1 % of the studied population, corresponding to 46.1 % of the 427 children that received prescriptions. "Alteration in dosage" was the commonest reason for off-label prescribing (28.2 %). The off-label prescriptions comprised mainly drugs acting on the "Respiratory System" and "Anti-infectious agents for systemic use". Amoxicillin/clavulanic acid, paracetamol, amoxicillin, ibuprofen and salbutamol were the five active principles most frequently prescribed off-label.
The prevalence of off-label drug prescribing in the Portuguese PEU of CHCB is high, the use in a dose or for an age group not approved in the SPC being the most common reasons for off-label prescription.
许多药物都是在药品上市许可规定的范围之外使用的(即“超说明书用药”)。有几项研究表明,这种情况在欧洲的各种医疗保健环境中都很常见。
本研究旨在定量和描述葡萄牙儿科病房(PEU)收治的儿童中超说明书用药的情况。
本研究在位于葡萄牙中东部科瓦达贝亚地区的科维利亚大学教学医院儿科病房(CHCB)进行。
这是一项描述性研究,纳入了 2010 年 1 月至 10 月间住院的 700 名儿童,通过回顾病历评估药物处方情况。超说明书用药定义为药物的适应证、年龄、剂量、给药频率或途径与药品说明书(SPC)推荐的不同。本研究仅研究出院后使用的药物。
超说明书用药是指药品的适应证、年龄、剂量、给药频率或途径与 SPC 推荐的不同。
共纳入 364 名男孩和 336 名女孩,年龄 4 天至 18 岁。724 种开具的药物中,32.2%为超说明书用药。在研究人群中,28.1%至少有一种药物被超说明书使用,其中 427 名接受处方的儿童中有 46.1%的药物被超说明书使用。“改变剂量”是超说明书用药最常见的原因(28.2%)。超说明书处方主要涉及“呼吸系统”和“全身抗感染药物”药物。最常被超说明书使用的五种活性药物分别为阿莫西林/克拉维酸、对乙酰氨基酚、阿莫西林、布洛芬和沙丁胺醇。
CHCB 的葡萄牙儿科病房中超说明书用药的情况很常见,最常见的原因是在 SPC 未批准的剂量或年龄组中使用。